AirSculpt Technologies, Inc. (AIRS)
Healthcare · NGM
Price as at 30 Sept 2026, 15:57 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
AirSculpt Technologies, Inc. trades at $1.77, close to the $1.84 our fair value estimate puts on the business. On this measure the market and the model broadly agree, so the interesting question is which of them is wrong.
Our moat model scores it 33 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
AIRS dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2022 | $0.410 | 1 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
AIRS earnings and analyst estimates
Recommendation mix, 3 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About AirSculpt Technologies, Inc.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Tampa, Florida.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
AIRS passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
5 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$2.12M · 0.0% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$1.68M · 0.0% of book
- Marshall Wace, MARSHALL WACE, LLP$1.30M · 0.0% of book
- Paul Tudor Jones, TUDOR INVESTMENT CORP ET AL$656.6K · 0.0% of book
- Two Sigma, TWO SIGMA INVESTMENTS, LP$278.0K · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
AIRS peers
The largest companies in the same industry (Medical Care Facilities), then in the same sector.
- FSNUY Fresenius SE & Co. KGaA
- THC Tenet Healthcare Corporation
- FMS Fresenius Medical Care AG
- ENSG The Ensign Group, Inc.
- UHS Universal Health Services, Inc.
- RHC.AX Ramsay Health Care Limited
- CHE Chemed Corporation
- CON Concentra Group Holdings Parent, Inc.
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is AirSculpt Technologies, Inc. (AIRS) undervalued?
Against our fair value estimate of $1.84, AIRS at $1.77 is 4% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own AIRS?
5 of the institutions we track reported a position in AIRS in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its AIRS data?
Fundamentals for AIRS come from company filings and exchange data, as listed on NGM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 15:57 UTC and is delayed. Our data quality score for this company is 83/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for AIRS, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.